Wenbo Sheng, Haitao Jiang, Hantao Yuan, Sibo Li
Department of Spine Surgery, Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, China;For correspondence:- Sibo Li Email: dr_lsb@163.com Tel:+8619921049422
Accepted: 5 February 2022 Published: 28 February 2022
Citation: Sheng W, Jiang H, Yuan H, Li S. Lugrandoside attenuates spinal cord injury by targeting peli1 and TLR4/NF-κB pathway to exert anti-inflammatory and anti-apoptotic effects. Trop J Pharm Res 2022; 21(2):245-251 doi: 10.4314/tjpr.v21i2.5
© 2022 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..
Archives
News Updates